Press release
Diabetic Gastroparesis Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | Theravance Biopharma, Eli Lilly and Company, Processa Pharmaceuticals, PTC Therapeutics
Diabetic Gastroparesis Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | Theravance Biopharma, Eli Lilly and Company, Processa Pharmaceuticals, PTC Therapeutics
DelveInsight's "Diabetic Gastroparesis Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of Diabetic Gastroparesis, historical and forecasted epidemiology as well as the Diabetic Gastroparesis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Diabetic Gastroparesis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Diabetic Gastroparesis Market Forecast [https://www.delveinsight.com/sample-request/diabetic-gastroparesis-market-size?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Some of the key facts of the Diabetic Gastroparesis Market Report:
*
The market size of Diabetic Gastroparesis was estimated to be ~USD 1,970 Million in the year 2023 and is expected to grow with a significant CAGR during the study period (2020-2034)
*
In September 2024, The US Food and Drug Administration (FDA) rejected the new drug application (NDA) from Vanda Pharmaceuticals for tradipitant intended for treating symptoms of gastroparesis. This decision was conveyed in a complete response letter (CRL).
*
In May 2024, CinDome Pharma, a CinRx portfolio company focused on developing safe, long-term treatments for gastroparesis, announced a $40 million extension to its Series B financing. This addition from existing investors, including Perceptive Advisors and CinRx Pharma, brings the total Series B funding to $59 million. The funds will be used to advance the enrollment and evaluation of deudomperidone in the Phase 2 envision3D study for adults with diabetic gastroparesis, as well as to prepare the company for future registrational trials.
*
In 2023, Germany recorded the largest market size among the EU4 and the UK, totaling around USD 225 million, followed by the UK, while Spain had the smallest market size.
*
According to estimates from DelveInsight, the total number of prevalent cases of Diabetic Gastroparesis in the 7MM was 14,950,000 in 2023, and this figure is expected to increase by 2034.
*
In 2023, the EU4 and the UK represented around 32% of the total prevalent cases of Diabetic Gastroparesis.
*
In 2023, approximately 40% of diabetic gastroparesis cases in the United States were linked to Type 1 diabetes. Patients with Type 1 diabetes are more often impacted by gastroparesis due to extended periods of high blood glucose levels, resulting in nerve damage, especially to the vagus nerve, which regulates stomach function.
*
In 2023, the United States exhibited the highest prevalence of diabetic gastroparesis among the seven major markets (7MM), with 85% of these cases undergoing treatment.
*
Key Diabetic Gastroparesis Companies: CINRx Pharma, Vanda Pharmaceuticals, Dr. Falk Pharma, and others.
*
Key Diabetic Gastroparesis Therapies: CIN-102, Tradipitant, Naronapride, and others
*
The Diabetic Gastroparesis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Diabetic Gastroparesis pipeline products will significantly revolutionize the Diabetic Gastroparesis market dynamics.
Diabetic Gastroparesis Overview:
Diabetic Gastroparesis is a condition characterized by delayed gastric emptying, which often occurs in individuals with diabetes. It is caused by nerve damage, particularly to the vagus nerve, which controls the muscles of the stomach. Symptoms can include nausea, vomiting, bloating, abdominal pain, and difficulty in controlling blood sugar levels. This delayed emptying can lead to poor digestion and nutrient absorption, making it challenging for patients to manage their diabetes effectively. Treatment options may include dietary changes, medications to stimulate gastric motility, and, in severe cases, interventions like gastric electrical stimulation.
Get a Free sample for the Diabetic Gastroparesis Market Report:
https://www.delveinsight.com/report-store/diabetic-gastroparesis-market-size [https://www.delveinsight.com/report-store/diabetic-gastroparesis-market-size?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Diabetic Gastroparesis Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Diabetic Gastroparesis Epidemiology Segmentation:
The Diabetic Gastroparesis market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
*
Total Prevalence of Diabetic Gastroparesis
*
Prevalent Cases of Diabetic Gastroparesis by severity
*
Gender-specific Prevalence of Diabetic Gastroparesis
*
Diagnosed Cases of Episodic and Chronic Diabetic Gastroparesis
Download the report to understand which factors are driving Diabetic Gastroparesis epidemiology trends @ Diabetic Gastroparesis Epidemiology Forecast [https://www.delveinsight.com/sample-request/diabetic-gastroparesis-market-size?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Diabetic Gastroparesis Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Diabetic Gastroparesis market or expected to get launched during the study period. The analysis covers Diabetic Gastroparesis market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Diabetic Gastroparesis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Diabetic Gastroparesis Therapies and Key Companies
*
CIN-102: CINRx Pharma
*
Tradipitant: Vanda Pharmaceuticals
*
Naronapride: Dr. Falk Pharma
Discover more about therapies set to grab major Diabetic Gastroparesis market share @ Diabetic Gastroparesis Treatment Market [https://www.delveinsight.com/sample-request/diabetic-gastroparesis-market-size?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Scope of the Diabetic Gastroparesis Market Report
*
Study Period: 2020-2034
*
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
*
Key Diabetic Gastroparesis Companies: CINRx Pharma, Vanda Pharmaceuticals, Dr. Falk Pharma, and others
*
Key Diabetic Gastroparesis Therapies: CIN-102, Tradipitant, Naronapride, and others
*
Diabetic Gastroparesis Therapeutic Assessment: Diabetic Gastroparesis current marketed and Diabetic Gastroparesis emerging therapies
*
Diabetic Gastroparesis Market Dynamics: Diabetic Gastroparesis market drivers and Diabetic Gastroparesis market barriers
*
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
*
Diabetic Gastroparesis Unmet Needs, KOL's views, Analyst's views, Diabetic Gastroparesis Market Access and Reimbursement
To know more about Diabetic Gastroparesis companies working in the treatment market, visit @ Diabetic Gastroparesis Clinical Trials and Therapeutic Assessment [https://www.delveinsight.com/sample-request/diabetic-gastroparesis-market-size?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Table of Contents
1. Diabetic Gastroparesis Market Report Introduction
2. Executive Summary
3. SWOT analysis
4. Diabetic Gastroparesis Patient Share (%) Overview at a Glance
5. Diabetic Gastroparesis Market Overview at a Glance
6. Diabetic Gastroparesis Disease Background and Overview
7. Diabetic Gastroparesis Epidemiology and Patient Population
8. Country-Specific Patient Population of Diabetic Gastroparesis
9. Diabetic Gastroparesis Current Treatment and Medical Practices
10. Diabetic Gastroparesis Unmet Needs
11. Diabetic Gastroparesis Emerging Therapies
12. Diabetic Gastroparesis Market Outlook
13. Country-Wise Diabetic Gastroparesis Market Analysis (2018-2030)
14. Market Access and Reimbursement of Therapies
15. Market drivers
16. Market barriers
17. Appendix
18. Diabetic Gastroparesis Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=diabetic-gastroparesis-market-to-show-remarkable-growth-trends-from-2024-to-2034-delveinsight-reports-theravance-biopharma-eli-lilly-and-company-processa-pharmaceuticals-ptc-therapeutics]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Diabetic Gastroparesis Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | Theravance Biopharma, Eli Lilly and Company, Processa Pharmaceuticals, PTC Therapeutics here
News-ID: 3781574 • Views: …
More Releases from ABNewswire
Why TMR Keyboards Are the Best Gaming Keyboards Available Now
TMR keyboards use advanced Tunnel Magnetoresistance sensors for higher sensitivity, lower power use, and more consistent performance than Hall Effect keyboards as reported by HLPLANET. Early models from MonsGeek, Womier, and Keychron are available, offering hot-swappable switches, various layouts, and wired/wireless options.
After a year dominated by Hall Effect mechanical keyboards, a new category of TMR-based keyboards [https://tmrkeyboard.com/] is starting to appear. These devices use Tunnel Magnetoresistance (TMR) sensors instead of…
New Jersey Chapter 7 Bankruptcy Attorney Daniel Straffi, Jr. Clarifies How Much …
Toms River, NJ - Daniel Straffi, Jr. of Straffi & Straffi Attorneys at Law (https://www.straffilaw.com/how-much-equity-can-i-have-in-my-home-and-still-file-for-chapter-7-bankruptcy-in-new-jersey) issued guidance on how much home equity can be protected when filing for Chapter 7 in New Jersey, addressing key rules, exemption choices, and timing considerations that determine whether a residence may be retained. The announcement provides practical direction for homeowners evaluating liquidation bankruptcy and highlights the options available under federal and New Jersey law.…
A New Book Challenges the Supreme Court's Rationale in Dobbs v. Jackson: A Fierc …
In their groundbreaking new book, The Unbearable Egregious Wrongness of Dobbs v. Jackson Women's Health Organization [https://a.co/d/im7abWO], legal scholars Michael Spivey and Kelsey S. Barnes offer a comprehensive and unflinching analysis of one of the most important Supreme Court decisions in recent history, including its devastating effects on women's rights, constitutional law, and judicial integrity in the United States.
The Supreme Court's 2022 Dobbs v. Jackson Women's Health Organization decision, which…
Top 5 Siding Companies in Marrero, LA: The Leading Experts Protecting and Transf …
Image: https://www.abnewswire.com/upload/2025/11/1844f0a7d8361f3ad98c64c11d6a48d0.jpg
Choosing the right siding contractor in Marrero, LA is one of the most important decisions a homeowner can make. With Louisiana's intense humidity, storm exposure, and rapid weather changes, siding doesn't just affect curb appeal; it protects your home from long-term damage. Marrero residents need siding companies that deliver craftsmanship, transparency, and durable materials built for the local climate.
Below is a detailed look at the Top 5 Siding Companies…
More Releases for Diabetic
Exploring The Diabetic Retinopathy Market In A Diabetic-Prevalent World: The Dri …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Diabetic Retinopathy Market Size Growth Forecast: What to Expect by 2025?
The diabetic retinopathy market has experienced robust expansion over the last few years, with projections indicating a rise from $8.61 billion in 2024 next year to $9.26 billion in 2025, reflecting a compound annual growth rate (CAGR) of…
Diabetic Socks Market Dynamics Shaped by Rising Diabetic Population - Persistenc …
The diabetic socks market is gaining significant traction worldwide, driven by the rising prevalence of diabetes and related complications such as diabetic neuropathy and foot ulcers. Designed specifically to cater to the needs of diabetic patients, these socks play a crucial role in foot protection by preventing blistering, reducing moisture accumulation, and providing cushioning to minimize the risk of ulcers. This article delves deeply into the diabetic socks market, exploring…
Diabetic Food Market
Future Market Insights (FMI) delivers key insights on the global diabetic food market in its latest report titled “Diabetic Food Market: Global Industry Analysis and Opportunity Assessment, 2014 – 2020”. The global diabetic food market is expected to amplify at a CAGR of 5.9% during the forecast period in terms of value due to various factors, regarding which FMI offers fundamental insights in detail in this report.
On the basis of…
Diabetic Food Market
Diabetes refers to a metabolic disease which leads to high blood sugar levels. The main cause behind diabetes is the insufficient insulin or no response in the body cells where the insulin is produced. Diabetic foods are dietary products rich in carbohydrates and sugar content. They help in controlling rising blood glucose. Diabetic food is low in calorie sweeteners and diet beverages. These products are consumed by diabetic patients and…
Demand for Diabetic Socks Due to Rising Prevalence of Diabetic Neuropathy Expect …
According to the latest market report published by Persistence Market Research titled ‘Diabetic Socks Market: Global Industry Analysis 2012-2016 and Forecast 2017-2025,’ the global diabetic socks market is expected to expand at a CAGR of approximately 4.8% during the forecast period 2017-2025.
To know key findings Request Sample Report @: https://www.persistencemarketresearch.com/samples/19282
Global Diabetic Socks Market: Factors Impacting the Market
The primary factors driving the growth of the global diabetic socks market are increasing…
Diabetic Food Market -
In recent times, diabetes has emerged as one of the most challenging health conditions across the world. According to the WHO, a total of 415 million cases of diabetes were reported globally in 2015. The count is rising at an alarming rate and is expected to reach 642 million in the next 25 years. Till now no medication has been found that can completely cure diabetes. It can only be…
